Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer : FDA Panel to Vote on Pfizer COVID-19 Shots for Kids; Data Shows Vaccine 90.7% Effective in Children Aged 5 to 11

10/22/2021 | 11:27am EST


ę MT Newswires 2021
All news about PFIZER, INC.
03:25pPfizer begins application for Canada's approval of COVID-19 pill
RE
03:14pPfizer Initiates Filling of Rolling New Drug Submission With Health Canada For COVID-19..
MT
03:10pPfizer begins application for Canada's approval of COVID-19 pill
RE
03:02pPfizer begins application for Canada's approval of COVID-19 pill
RE
12:08pGLOBAL MARKETS LIVE : Merck, Volkswagen, Salesforce, Roche, Mondelez...
11:10aWALL STREET STOCK EXCHANGE : The Fed takes a new stance
06:50aEU To Start Early COVID-19 Vaccinations For Children Aged Five To 11
MT
06:12aEU To Roll Out Pfizer-BioNTech COVID-19 Shot For Younger Children Ahead of Schedule, St..
MT
04:46aPrada Exploring Opportunities In Second-Hand Fashion
MT
01:22aJapan begins administering Pfizer booster doses
AQ
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 517 M - -
Net income 2021 21 354 M - -
Net Debt 2021 27 873 M - -
P/E ratio 2021 13,8x
Yield 2021 2,94%
Capitalization 302 B 302 B -
EV / Sales 2021 4,04x
EV / Sales 2022 3,80x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 53,73 $
Average target price 49,58 $
Spread / Average Target -7,73%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Susan Silbermann President & General Manager-Pfizer Vaccines
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.45.97%301 579
JOHNSON & JOHNSON-0.92%410 501
ROCHE HOLDING AG16.39%337 091
NOVO NORDISK A/S65.17%243 741
ELI LILLY AND COMPANY46.91%224 871
ABBVIE INC.7.59%203 801